Chemoinformaics analysis of DEMETHYLMORACIN I
| Molecular Weight | 310.349 | nRot | 3 |
| Heavy Atom Molecular Weight | 292.205 | nRig | 17 |
| Exact Molecular Weight | 310.121 | nRing | 3 |
| Solubility: LogS | -3.347 | nHRing | 1 |
| Solubility: LogP | 5.091 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 46.9403 |
| nHD | 3 | BPOL | 19.7937 |
| QED | 0.612 |
| Synth | 2.748 |
| Natural Product Likeliness | 1.826 |
| NR-PPAR-gamma | 0.448 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.646 |
| HIA | 0.008 |
| CACO-2 | -4.967 |
| MDCK | 0.0000149 |
| BBB | 0.015 |
| PPB | 0.990307 |
| VDSS | 1.133 |
| FU | 0.0206405 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.38 |
| CYP2c19-inh | 0.941 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.734 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0.947 |
| CYP2d6-sub | 0.899 |
| CYP3a4-inh | 0.805 |
| CYP3a4-sub | 0.121 |
| CL | 11.489 |
| T12 | 0.695 |
| hERG | 0.085 |
| Ames | 0.038 |
| ROA | 0.116 |
| SkinSen | 0.931 |
| Carcinogencity | 0.068 |
| EI | 0.846 |
| Respiratory | 0.583 |
| NR-Aromatase | 0.883 |
| Antiviral | Yes |
| Prediction | 0.773948 |